The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Indirect treatment comparison (ITC) of momelotinib (MMB) vs fedratinib (FED) safety in patients (pts) with myelofibrosis (MF).
 
Lucia Masarova
No Relationships to Disclose
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Sierra Oncology
Research Funding - AbbVie (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Galecto (Inst); Geron (Inst); Incyte (Inst); Kartos Therapeutics (Inst); PharmaEssentia (Inst); Protagonist Therapeutics (Inst); Sierra Oncology (Inst); Telios (Inst)
 
Francesca Palandri
Honoraria - AOP Orphan Pharmaceuticals; Celgene; CTI; Novartis; Sierra Oncology
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; Celgene; CTI; Novartis; Sierra Oncology
 
Ruben A. Mesa
Consulting or Advisory Role - Constellation Pharmaceuticals; La Jolla Pharma; Novartis; Sierra Oncology
Research Funding - Abbvie (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Genentech (Inst); Incyte (Inst); Mays Cancer Center (Inst); NCI (Inst); Promedior (Inst); Samus (Inst)
 
Claire Harrison
Honoraria - Abbvie; CTI BioPharma Corp; Geron; Janssen; Novartis
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; Celgene; Constellation Pharmaceuticals; CTI; Galecto; Geron; Gilead Sciences; Janssen; Keros Therapeutics; Novartis; Promedior; Roche; Shire; Sierra Oncology
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; CTI BioPharma Corp; Geron; Novartis; Sierra Oncology
Research Funding - Bristol-Myers Squibb (Inst); Constellation Pharmaceuticals (Inst); Novartis (Inst)
 
Gautam Sajeev
No Relationships to Disclose
 
Boris Gorsh
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Ryan Simpson
No Relationships to Disclose
 
Sang Kyu Cho
No Relationships to Disclose
 
Zhaohui Wang
Employment - GlaxoSmithKline
 
Catherine Elizabeth Ellis
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Seán Conlon
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
James Signorovitch
No Relationships to Disclose